Related Experiment Video

Updated: Jun 10, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

SV40 associated miRNAs are not detectable in mesotheliomas

G V Gee1, M L Stanifer, B C Christensen

  • 1Department of Pathology and Laboratory Medicine, Brown University, Box G-E-5, Providence, RI 02912, USA.

British Journal of Cancer
|August 19, 2010
PubMed
Abstract

Insights

Simian virus-40 (SV40) microRNAs are not detected in human mesothelioma. This study developed sensitive assays, finding no evidence of SV40 miRNA involvement in mesothelioma tumourogenesis.

Area of Science:

  • Virology
  • Oncology
  • Molecular Biology

Background:

  • Simian virus-40 (SV40) is a DNA tumor virus linked to human cancers, particularly mesothelioma.
  • The role of SV40 in mesothelioma is controversial due to limitations in current diagnostic tests, including false positives from cross-reactivity and contamination.
  • The Institute of Medicine recommends developing more sensitive and specific tests to clarify SV40's role.

Purpose of the Study:

  • To develop and characterize highly sensitive and specific reverse transcription PCR (RT-PCR) based assays for detecting SV40-encoded microRNAs (miRNAs).
  • To investigate the presence and potential role of SV40 miRNAs in human malignant pleural mesothelioma (MM).
  • To provide a more reliable diagnostic method for SV40 detection compared to existing PCR-based tests.

Main Methods:

  • Characterization of novel, highly sensitive RT-PCR assays specifically designed to detect SV40-encoded miRNAs.
  • Application of these assays to analyze human malignant pleural mesothelioma (MM) tissue samples.
  • Comparison of the developed miRNA detection method with current, less specific testing approaches.

Main Results:

  • The developed RT-PCR assays demonstrated high sensitivity and specificity for SV40 miRNAs.
  • SV40 miRNA expression was not detected in any of the analyzed human malignant pleural mesothelioma (MM) samples.
  • This finding contrasts with the potential for false positives in previously used SV40 detection methods.

Conclusions:

  • SV40 miRNAs are unlikely to play a significant role in the development of mesothelioma.
  • The developed miRNA-specific RT-PCR assays represent a valuable advancement over current, less specific methods for SV40 detection.
  • Further research utilizing sensitive and specific molecular tools is crucial for resolving controversies in viral oncology.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...